CCR7 and cancer: In the tumor microenvironment, CCL21 acts as a potent chemoattractant for CCR7-positive tumor cells by binding to podoplanin on cancer-associated fibroblasts (CAFs), thereby promoting the stromal invasion of cancer cells [25].